SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Topics Monthly Activity About

Correspondence Activity Detail

Acurx Pharmaceuticals, Inc. (ACXP)
Activity window: Sep. 25, 2025 to Sep. 24, 2026

Correspondence Filings
3
Keyword Matches
0
Latest Activity
Jul. 21, 2025
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
May. 7, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on May 4, 2026. The letter emphasizes the company's responsibili… Read Filing EDGAR
May. 7, 2026 UPLOAD Neutral/Informational Low The SEC has notified Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on Form S-1. The letter emphasizes that the responsibility for the accu… Read Filing EDGAR
May. 7, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request for acceleration of the effective date of its Registration Statement on Form S-1, seeking to have it become effective on May 11… Read Filing EDGAR
May. 7, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-1. The company aims for the regis… Read Filing EDGAR
Feb. 9, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on February 2, 2026. The letter emphasizes that the responsibili… Read Filing EDGAR
Feb. 9, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request for acceleration of the effective date of its Registration Statement on Form S-1, seeking to have it become effective on Februa… Read Filing EDGAR
Jan. 2, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request to the U.S. Securities and Exchange Commission to accelerate the effective date of their Registration Statement on Form S-3 to … Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.